Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 2/3 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 28Neoplasm Metastasis 6Recurrence 5Breast Neoplasms 4Stomach Neoplasms 3Prostate Cancer Metastatic 3Neoplastic Cells, Circulating 3Carcinoma, Transitional Cell 3Carcinoma, Non-Small-Cell Lung 3Ovarian Neoplasms 2Brain Neoplasms 2Urinary Bladder Neoplasms 1Testicular Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Prostatic Neoplasms, Castration-Resistant 1Prostate Cancer, Hereditary, 7 1Penile Neoplasms 1Nonseminomatous germ cell tumor 1Metastatic Castration-resistant Prostate Cancer, MCRPC 1Metastatic Castration-resistant Prostate Cancer 1Metastatic Breast Cancer With Intracranial Metastases 1Lung Neoplasms 1Liposarcoma 1Hormone-Resistant Prostate Cancer 1Hormone Refractory Prostate Cancer 1Head and Neck Neoplasms 1Glioblastoma 1Esophageal Neoplasms 1Diarrhea 1

Interventions

pembrolizumab 31Gemcitabine 26Nivolumab 20atezolizumab 16Cisplatin 15avelumab 14Carboplatin 12Docetaxel 10enfortumab vedotin 8Magnetic Resonance Spectroscopy 8durvalumab 7Specimen Handling 7Paclitaxel 7Ipilimumab 6toripalimab 5pemigatinib 5cabozantinib 5vinflunine 4sacituzumab govitecan 4Taxes 4Pemetrexed 4tislelizumab 3cabazitaxel 3Standard of Care 3Mitomycin 3Injections 3Everolimus 3Albumin-Bound Paclitaxel 3sapanisertib 2olaparib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Carcinoma, Transitional Cell × cabazitaxel × Clear all
NCT01616875 2026-03-06

Bristol Bladder Trial

University Hospitals Bristol and Weston NHS Foundation Trust

Phase 2 Completed
28 enrolled 21 charts
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT01437488 2025-05-04

Cabazitaxel in Patients With Urothelial Carcinoma Who Have Disease Progression Following Platinum-Based Chemotherapy

Thomas Jefferson University

Phase 2 Completed
14 enrolled 12 charts
Genitourinary

Carcinoma, Transitional Cell

NCT01600339 2015-05-12

A Trial of Cabazitaxel for Advanced Transitional Cell Carcinoma (TCC)

Rambam Health Care Campus

Phase 2 Completed
19 enrolled
Genitourinary

Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡